Inactive Instrument

News Wize Pharma Inc OTC Bulletin Board

Equities

End-of-day quote OTC Bulletin Board Other stock markets
- ^USD	-

2021	Insider Trends: Wize Pharma Insider 90-Day Buying Trend Added to with Purchase	MT
2021	Insider Trends: Insider Buying Continued with Purchase of Wize Pharma Stock	MT

Summary

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Wize Pharma : to change name to Mawson Infrastructure Group Inc	21-03-25	AQ
MAWSON INFRASTRUCTURE GROUP INC. : Amendments to Articles of Inc. or Bylaws; Change in Fiscal Year, Financial Statements and Exhibits (form 8-K)	21-03-23	AQ
Insider Trends: Wize Pharma Insider 90-Day Buying Trend Added to with Purchase	21-03-11	MT
Insider Trends: Insider Buying Continued with Purchase of Wize Pharma Stock	21-03-11	MT
Insider Trends: Insider Purchase Adds to Wize Pharma Positive Trend	21-03-11	MT
WIZE PHARMA, INC. : Completion of Acquisition or Disposition of Assets, Unregistered Sale of Equity Securities, Changes in Control or Registrant, Change in Directors or Principal Officers, Submission of Matters to a Vote of Security Holders, Financial Statements and Exhibits (form 8-K)	21-03-10	AQ
WIZE PHARMA : MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS. (form 10-K)	21-03-01	AQ
Vertua Limited (NSX:VERA) Cosmos Investment Impact	21-02-21	AQ
WIZE PHARMA, INC. : Regulation FD Disclosure, Financial Statements and Exhibits (form 8-K)	21-02-16	AQ
WIZE PHARMA, INC. : Other Events, Financial Statements and Exhibits (form 8-K)	21-02-04	AQ
WIZE PHARMA, INC. : Entry into a Material Definitive Agreement, Unregistered Sale of Equity Securities, Financial Statements and Exhibits (form 8-K)	21-01-19	AQ
WIZE PHARMA, INC. : Entry into a Material Definitive Agreement, Unregistered Sale of Equity Securities, Other Events, Financial Statements and Exhibits (form 8-K)	21-01-05	AQ
Wize Pharma : Receives Bonus BioGroup Shares from Escrow and Additional Bonus BioGroup Shares Totaling $1.3 Million	21-01-04	PR
WIZE PHARMA, INC. : Material Modification to Rights of Security Holders (form 8-K)	20-12-31	AQ
WIZE PHARMA, INC. : Regulation FD Disclosure, Financial Statements and Exhibits (form 8-K)	20-12-31	AQ
Wize Pharma : and Cosmos Capital enter into Bid Implementation Agreement	20-12-30	PR
WIZE PHARMA, INC. : Unregistered Sale of Equity Securities (form 8-K)	20-12-09	AQ
WIZE PHARMA, INC. : Entry into a Material Definitive Agreement, Financial Statements and Exhibits (form 8-K)	20-11-30	AQ
WIZE PHARMA : Management's Discussion and Analysis of Financial Condition and Results of Operations (form 10-Q)	20-11-16	AQ
Wize Pharma : Announces Positive Topline Results in Phase IV Study of LO2A for the Treatment of Dry Eye Syndrome in Patients with Sjögren's Syndrome	20-11-12	PR

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

News Wize Pharma Inc OTC Bulletin Board

Equities

Summary

Filters